A carregar...

Cancer Subclonal Genetic Architecture as a Key to Personalized Medicine

The future of personalized oncological therapy will likely rely on evidence-based medicine to integrate all of the available evidence to delineate the most efficacious treatment option for the patient. To undertake evidence-based medicine through use of targeted therapy regimens, identification of t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Rehemtulla, Alnawaz
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884532/
https://ncbi.nlm.nih.gov/pubmed/24403863
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!